Reborn Coffee (NASDAQ:REBN – Get Free Report) and Kenvue (NYSE:KVUE – Get Free Report) are both consumer staples companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, institutional ownership, risk and profitability.
Earnings and Valuation
This table compares Reborn Coffee and Kenvue”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Reborn Coffee | $5.93 million | 1.71 | -$4.81 million | ($2.56) | -0.66 |
| Kenvue | $15.12 billion | 2.31 | $1.47 billion | $0.77 | 23.69 |
Profitability
This table compares Reborn Coffee and Kenvue’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Reborn Coffee | -191.48% | -995.56% | -170.77% |
| Kenvue | 9.72% | 19.72% | 7.72% |
Institutional & Insider Ownership
1.8% of Reborn Coffee shares are held by institutional investors. Comparatively, 97.6% of Kenvue shares are held by institutional investors. 24.0% of Reborn Coffee shares are held by company insiders. Comparatively, 1.7% of Kenvue shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Ratings
This is a breakdown of current ratings for Reborn Coffee and Kenvue, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Reborn Coffee | 1 | 0 | 0 | 0 | 1.00 |
| Kenvue | 0 | 12 | 3 | 0 | 2.20 |
Kenvue has a consensus price target of $19.50, suggesting a potential upside of 6.91%. Given Kenvue’s stronger consensus rating and higher possible upside, analysts clearly believe Kenvue is more favorable than Reborn Coffee.
Volatility and Risk
Reborn Coffee has a beta of 2.13, meaning that its share price is 113% more volatile than the S&P 500. Comparatively, Kenvue has a beta of 0.51, meaning that its share price is 49% less volatile than the S&P 500.
Summary
Kenvue beats Reborn Coffee on 12 of the 14 factors compared between the two stocks.
About Reborn Coffee
Reborn Coffee, Inc., through its subsidiaries, operates and franchises retail locations, kiosks, and cafes that focus on serving specialty-roasted coffee in California. It purchases, roasts, and sells coffee, tea and other beverages, and various food items. It offers products in various form factors, such as whole bean roasted coffee bags, single-serve drip bags, and pour over packs. The company also offers its products online. Reborn Coffee, Inc. was founded in 2014 and is headquartered in Brea, California.
About Kenvue
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.
Receive News & Ratings for Reborn Coffee Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reborn Coffee and related companies with MarketBeat.com's FREE daily email newsletter.
